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A brief literature review on recent progress in nanopore thin 
film-based optical sensors 
 
Guantong Zhou 
Electrical and Computer Engineering Department 
Iowa State University 
 
 
 
Abstract. Anodic aluminum oxide (AAO) material is broadly used in biomedical and biosensing 
applications nowadays. Most of the AAO nanopore thin film sensors are usually fabricated on a glass 
substrate. By bonding the AAO nanopore thin film sensors to a layer of transparent polymer thin film (pTF) 
made with polydimethylsiloxane (PDMS), a new type of flexible nanopore sensors has been developed. 
The AAO thin film based flexible sensing platform has been used for  pressure sensing, temperature sensing, 
angular sensing, and for disease biomarker detection. This short review will summarize some recent 
progress using the AAO nanopore thin film as the drug storage and release device, the flexible optical 
nanopore sensors with improved resolution, and several applications based on the optical properties. 
 
 
1. Introduction 
The nanopore-based optical sensors have 
multiple uses in different fields and has a great 
potential to be used as pressure sensors, 
temperature sensors and drug loading and 
releasing devices. Furthermore, nanopore-based 
optical sensors can also be used within the 
biomedical industry. This paper will summarize 
the recent progress with the nanopore-based 
optical sensors that can be used in multiple ways. 
Usually the nanomaterials used within this 
industry is Anodic aluminum oxide (AAO) 
[1][2], which is also the material that being used 
in the research. This material is able to be 
fabricated by the anodization process, and based 
on its unique optical properties, a lot of devices 
have been developed, such as gas sensors, 
colorimetric sensors, cancer biomarker sensors 
and drug storage and release devices [3].  
The drug loading and release nanopore 
thin film device was reported in 2017 by Chao 
Song, et al [4]. The nanopore thin film is made 
with a layer of AAO and consists of nanopores 
with a honeycomb shape. The drug, which was 
modeled with gentamicin sulfate (GS), was 
loaded to the device using the layer-by layer 
(LbL) nanoassembly processes. The drug was 
stacked on each layer while loading, and the 
device was immersed in the flowing DI water to 
release the drug. These two processes are both 
able to be monitored with an optical 
spectrometer. The drug releasing rate can be 
modified  by changing the size and the density of 
the nanopore [4]. 
By bonding the AAO nanopore sensors 
onto a layer of polydimethylsiloxane (PDMS) is 
able to perform as a pressure sensor and drug 
release device. Such a device was reported in 
early 2018 [3]. Similar with the last device, the 
layer of AAO contains periodically distributed 
honeycomb-shape nanopores, which can be used 
to store and release drugs. With a layer of PDMS 
serving as the substrate of the sensors, the 
flexibility of the device would increase 
significantly. As the sensors benefits from 
flexibility, besides serving as the drug loading 
and releasing device, it’s also able to measure the 
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pressure applied on the sensor. By monitoring the 
optical interference fringes shift and the change 
of the incident angles of the optical light 
illuminated on the device caused by the device 
deformation. The result indicated that the 
pressure sensor would have the pressure 
sensitivity at 0.01nm/mmHg [3]. 
These AAO optical nanopore sensors 
were used in the multiplexed biomarkers 
detectors introduced in 2018, which are able to 
monitor the level of beta-amyloid (Aβ42) and 
total-tau (T-tau) in buffer or cerebrospinal fluid 
(CSF). Both Aβ42 and T-tau are the best 
biological markers that can diagnose Alzheimer’s 
disease with high reliability and validity [5]. This 
device is able to monitor the level of these two 
biomarkers, which would be a great tool for 
point-of-care to diagnose the Alzheimer’s 
disease. The biomarker sensors used in this 
device were adapted from the previous works in 
our lab [6][7][8]. Fabricated AAO thin film on the 
glass substrate would be bonded with the PDMS 
microfluidic layer [9][10]. The antibodies of both 
biomarkers were functionalized on the surface of 
the sensors which are able to detect the 
biomarkers. The optical signal would shift if the 
biomarkers were detected, and the results would 
be displayed by a spectrometer. The 
concentrations of two biomarkers as low as 1 μl 
are able to be detected [5]. 
The way of improving the optical 
resolution and flexibility was introduced in 2018 
by bonding the transparent AAO thin film layer 
to a polymer thin film (pTF) [11]. The quality 
factor (Q) and optical resolution are able to be 
improved significantly with pTF-nanopore 
sensor. The thickness of the pTF would affect the 
performance of the optical sensor from the 
experiments. From the results, better resolution is 
achievable when the thickness of the pTF layer 
and AAO layer are 80 μm and 2 μm. The device 
is able to measure the angle of illuminated light 
with a sensitivity of 0.4 nm/deg with 0.2 deg 
resolution [11]. The optical signal would also be 
affected by the change of surrounding 
temperature at a sensitivity of 0.2 nm/℃ with 
resolution of 1 ℃. This property made this device 
a great temperature sensor. The pTF-nanopore 
sensor has better optical resolution, transparency 
and flexibility than the normal AAO nanopore 
sensors, and it has a great potential to be used as 
a wearable disease biomarkers monitor. It also 
can be fabricated as a smart contact lens to 
monitor the intraocular pressure for the glaucoma 
diagnosis [11]. 
All the works aforementioned in this 
brief review include the fabrication processes, 
measurements and results. All the techniques 
involved in these studies are based on the 
nanopore optical sensors made with AAO thin 
film, and the optical transducing signal is the 
reflected light from the device, which can be 
monitored with a spectrometer. 
Fig 1. Schematic drawing of AAO structure [12] 
 
Anodic aluminum oxide (AAO) has been 
developed and used in the biomedical industry for 
a long period of time because of the nanoscale 
pore structure, which contains an array of parallel 
hexagonal nanopores as shown in Fig 1. This 
nanopores structure is perpendicular to the 
Aluminum (Al) substrate on the bottom, and the 
structure can be characterized with several 
parameters: pore diameter, interpore distance, 
pore organization, pore length, pore sidewall and 
barrier layer thickness. All these parameters are 
able to be controlled by modifying the 
anodization conditions during fabrication 
process. The porous oxide layer thickness is 
usually in range between 0.01 μm and 150 μm 
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[12]. The AAO thin film that were using in the 
research has the thickness  of ~2 μm to 3 μm.  
 
2. Recent Applications 
2.1. Drug loading and releasing device [4] 
2.1.1. Introduction and Methods 
 Locally sustained drug delivery is an 
ideal process for various diseases such as some 
ocular diseases, chronic diseases and coronary 
heart disease [13][14]. In order to achieve this 
goal, many types of nanostructured devices have 
been developed. For instance, the device can 
control drug delivery that made with porous Si 
[15] and the synthesize capsules of the nanoscale 
drug [16][17]. A drug loading and releasing 
nanopore thin film was studied and designed in 
our lab, which was made with anodic aluminum 
oxide (AAO) material that introduced in the 
previous section and enabled by the layer-by-
layer (LbL) nanoassembly process. The LbL 
nanoassembly is realized by the electrostatic 
attraction between the polyelectrolytes with 
opposite charge. The relation between the drug 
releasing time and the nanopore size has also 
been studied.  
 In this research, the drug is modeled by 
gentamicin sulfate (GS), and it would be stacked 
between polyacrylic acid (PAA) and chitosan 
(CHI) layers in the nanopore as shown in Fig 2 
(a). The concentration of GS, PAA and CHI are 
diluted with phosphate-buffered saline 6.5 (PBS 
6.5) to 2, 5 and 0.12 mg/ml, respectively. These 
three different layers would be applied onto the 
nanopore thin film in a certain order repeatedly. 
The layer of [PAA/GS/PAA/CHI] would be 
formed with the LbL nanoassembly process due 
to the opposite charge and electrostatic force 
between them. The PAA layer would be rinsed 
with PBS 6.5 two times after being applied with 
the positive charge on the oxygen plasma treated 
Au-coated nanopore thin film in order to remove 
the less firmly bonded PAA from the surface. 
This same procedure would be followed for each 
layer until ten [PAA/GS/PAA/CHI] layers have 
been loaded on the nanopore surface as shown in 
Fig 2 (a-c). From immersing into the DI water, 
the drug would be able to release as shown in the 
Fig 2 (d). 
 Both of drug loading and releasing 
processes are able to be monitored optically by 
using the reflected light as transducing signal, 
which is shown in Fig 3. The setup of the optical 
monitoring includes the white light source, 
spectrometer, illuminating and collecting optical 
Fig 2. (a) Loading process with LbL nanoassembly process. (b) Before Drug Loading. (c) After drug loading. (d) Releasing 
process by flowing DI water. 
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fiber and laptop to show the spectrums. The 
spectrometer would collect the interference 
fringes reflected from the nanopore thin film. 
When the drug layer is loaded or released, the 
effective refractive index would be changed, 
which would lead to the optical signal shift. The 
refractive indexes of each PAA, CHI and GS 
layers are 1.442, 1.35 and 1.58, respectively [4].  
 
2.1.2. Results and Discussion 
The optical measurement would be 
performed for each [PAA/GS/PAA/CHI] layer 
during drug loading process, and all eleven 
results would be recorded and plotted in Fig 4. 
The wavelength peak at 609 nm was selected as 
the reference peak. The first two layers shift the 
wavelength peak to 607.8 nm and the rest of the 
layers make the wavelength peak shift to 612.3 
nm. The value of wavelength peak shift 
corresponding to the number of layers is shown 
in Fig 4. (b). The relationship between thickness, 
resonant wavelength and the refractive index of 
this device is given by the equation: 2(𝑛3𝑡 +𝑛2𝑑 − 𝑛1𝑡 − 𝑛0𝑑) = 𝑚𝜆 , where 𝑑  is the 
thickness of the chemicals above the AAO 
surface, 𝑡 is the thickness of the AAO structure, 
and 𝑛0, 𝑛1, 𝑛2	and 𝑛3 are the effective refractive 
index of the chemicals deposited above the 
nanopore, the chemicals filled in nanopore, the 
chemicals on AAO surface, and AAO itself, 
respectively. The wavelength peak shift to the 
smaller value for the first two layers; the reason 
for this is that the chemicals are also deposited 
into the nanopore of AAO, and the chemicals 
deposited on the surface is less than the chemicals 
trapped in nanopore. The wavelength increases 
like a linear function after exceeding the second 
layers, and this indicated that the chemical layers 
are deposited on the AAO surface uniformly. 
 By immersing the device into the 
flowing DI water, the drug loaded on the device 
would start releasing. The results of monitoring 
the optical signal are shown in Fig 5. Changing 
the solution from PBS 6.5 to DI water would 
change the chemical ionization, which would 
make the bonding force weaker and the drug 
Fig 3. (a) Optical Monitoring setup. (b) Schematic of incident 
light reflected on nanopore surface. (c) Optical light as 
transducing signal. [4] 
Fig 4. (a) Measured Optical Signals after each layer has been loaded. (b) shift of wavelength peak 
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layers on the top start to dissolve. The wavelength 
peak shift had been observed for releasing time at 
2, 120, 600, 1440 and 2880 minutes, and the 
results indicated that the chemicals inside the 
nanopore would take much longer time to release 
relatively. 
Additionally, the drug loading and 
releasing are affected by the nanopore size and 
volume, which is also studied during the research. 
The comparison results between the AAO 
nanopore with 10 nm and 50 nm size shows that 
the drug accommodation and releasing time are 
increasing with the size and density of the 
nanopore. Furthermore, the AAO nanopore thin 
film is able to be used as an implantable drug 
delivery device because of the biocompatibility 
and the succession in transferring onto the 
PDMS-silicon membrane [4]. 
 
 
2.2. Pressure sensor and drug releasing device 
[1] 
2.2.1. Introduction and Methods 
 In order to integrate sensors into 
wearable devices, fabricating the nanoscale 
devices onto the deformable polymer substrates 
instead of rigid substrates is getting popular 
recently. For example, flexible fluorescence 
sensors and piezoresistive strain sensors are both 
having a lot of potential uses for disease diagnosis 
if they can be integrated onto a curvilinear 
substrate. Several different nanomaterials have 
been developed, which have shown people the 
significant potentials on drug loading and 
delivery system. In this research, the similar 
AAO structure that developed in the last research 
were fabricated onto a layer of 
Polydimethylsiloxane (PDMS), which was using 
as a flexible substrate. This device is not only able 
to implement the same drug loading and release 
process, it’s also able to be used as a pressure 
sensor since the device deformation would cause 
the optical shift of the reflected interference 
fringes.   
 The drug model is also simulated with 
gentamicin sulfate (GS) as the last research, and 
it would be stacked between polyacrylic acid 
(PAA) and chitosan (CHI) with the layer-by-layer 
(LbL) nanoassembly processes. A layer of 
periodically distributed honeycomb-shape 
Fig 5. (a) Measured optical signals after certain releasing time. (b) Wavelength shift with releasing time 
Fig 6. (a-b) FLEX-nanopore-TF. (c-d) SEM images showing 
the AAO nanopore 
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nanopores on this flexible nanopore thin film 
(FLEX-nanopore-TF) device is fabricated from 
the layer of a high purity aluminum on the glass 
substrate from an anodization process. Then, the 
AAO nanopore thin film would be immersed in 
the liquid PDMS and cured under 65℃ for two 
hours. The FLEX-nanopore-TF can be peeled off 
from the glass substrate.  
The drug model is able to be loaded onto 
the nanopore surface with LbL nanoassembly and 
released by immersing into flowing DI water as 
the last research as shown in Fig 2 and Fig 7 (a-
c). Similarly, the processes of the loading and 
releasing can be monitored with transducing 
optical signals captured with a spectrometer.  
 By monitoring the transducing optical 
signal, the pressure applied on the device can be 
monitored. Initially, the illuminated light is 
perpendicular to the nanopore thin film. The 
PDMS layer would start bending under the 
applied pressure, and the incident angle θ of the 
illuminated light would change. A different 
change of incident light angle θ would lead to a 
different optical shift of the reflected interference 
fringes peaks, which can be used as the 
transducing signal of the applied pressure as 
shown in Fig 8. In our research, the size of the 
device is 18 mm long, 13 mm wide and 1.5 mm 
thick with a 50 nm nanopore. The reliability of 
the device had been studied and showed no cracks 
after hundreds of bendings. 
 
2.2.2. Results and Discussion 
 As shown in Fig 8 (c-d), the wavelength 
peak would move to the left when the illuminated 
light incident angle θ is enlarged. When the 
illuminated light reflected from the FLEX-
nanopore-TF, the angle was changed from 0° to 
5°, 10°, 15° and 20°. As the corresponding peak 
shift to each incident angle, the optical signal shift 
change is 1.2 nm, 3.2 nm, 7.6 nm and 14.8 nm, 
respectively. 
The pressure applied on the device along 
the horizontal direction can be calculated in 
mmHg unit. The peak of the reflected optical 
signals under different pressures are shown in Fig 
9. The results show that the wavelength peak is 
shifting to smaller values when the applied 
pressure increased, and the measurement results 
are consistent with the simulation. The sensitivity 
of the device is 0.01 nm/mmHg. This result 
provides the industry with a new optical platform 
to measure the pressure and can be integrated to 
the wearable as a disease diagnosis monitor. 
Fig 7. (a-c) Sketch of the device with periodically distributed 
nanopores loaded with drugs. (d-e) Reflected light will have 
an optical interference fringes shift when the device deformed 
under pressure. 
Fig 8. (a-b) Incident light angle changed when the PDMS 
substrate bending under applied pressure. (c-d) Shift of the 
reflected optical interference fringes peak as the transducing 
signal. 
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The drug loading and releasing processes 
are similar with the first research in section 2.1. 
Ten [PAA/GS/PAA/CHI] layers were loaded 
onto the AAO surface, and the reflected optical 
signals would be monitored after each layer 
deposited. Same as the last research, the 
wavelength peak had blueshift to 643 nm from 
bare AAO thin film 647 nm for the first two 
layers and redshift eventually to 684 nm from the 
third layers until the tenth layer as shown in Fig 
10 (a-b). This shift is caused by the thickness of 
the coated layers, which changed the refractive 
index of the nanopore film. This reason is 
different from the illuminated light angles change 
for the pressure measuring purpose. 
The drug will be released when the 
device is immersed into flowing DI water and the 
reflected optical signals were measured for 0, 2, 
120, 600 and 1440 minutes. As shown in Fig 10 
(c-d), the peak has a 1 nm blueshift for the first 
two minutes, which indicated that the drugs 
loaded on the AAO surface had been released in 
the DI water. Then, the peak had a redshift and it 
indicated that the drugs loaded inside that 
nanopores start to release. The curve shown in Fig 
10(d) indicated that the drug inside the nanopore 
is harder to be released compared to the drug 
loaded on the AAO surface. The releasing 
processes had been extended to 21 days, and data 
indicated that the shift of the reflected optical 
signal kept increasing until eighth day and 
eventually stop from the fifteenth day, which 
indicated that the drugs had been fully released.  
 
 
 
 
Fig 9. (a) Optical reflected signal under different pressures. (b) Shift of the optical signal peak under measurement and simulation 
Fig 10. (a-d) Reflected interference fringes shift during FLEX-
nanopore-FT drug loading and releasing processes 
Fig 11. Measure drug release curve in 21 days 
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2.3. Alzheimer's disease biomarkers detection 
device [5] 
2.3.1. Introduction and Methods 
 Alzheimer’s disease (AD) is the most 
prevalent dementia type throughout the world. 
The way to diagnosis the AD disease has been 
improving for last few decades, such as 
neuroimaging method. Increasing the sensitivity 
and accuracy of the diagnosis is still a challenge 
for the industry. The best biomarkers to diagnosis 
the Alzheimer’s disease are beta-amyloid (Aβ42) 
and total-tau (T-tau) inside patients’ 
cerebrospinal fluid (CSF) with high reliability 
and validity. The existing method to measure 
these biomarkers, such as neuroimaging or 
enzyme-linked immunosorbent assay (ELISA) 
method, are typically expensive and challenge to 
perform [18][19], which is not suitable for point-
of-care (POC) diagnostics. A label-free optical 
nanosensors that can be used to monitor the level 
of beta-amyloid (Aβ42) and total-tau (T-tau) was 
introduced in this research. 
 The device contains four sensors, which 
were fabricated with the anodic aluminum oxide 
(AAO) nanopore thin film on a PDMS layer and 
glass substrate as shown in Fig 12 (A-C). One of 
these sensors is used as control experiment and 
the other sensors are used to measure Aβ42, T-
tau, and the mixture of Aβ42 and T-tau. Similar 
as the previous works, the reflected optical 
interference fringes would be used as a 
transducing signal.  
 The materials, include Aβ42 biomarker 
and antibody, T-tau biomarker and antibody, 
sample cerebrospinal fluid, 11-
Mercaptoundecanoic acid (𝐻𝑆𝐶01𝐶𝑂𝑂𝐻, 99%), 
8-Mercapto-1-Octanol ( 𝐻𝑆𝐶3𝑂𝐻 , 98%), 
N-(3-Dimethylaminopropyl)-N′-
ethylcarbodiimide hydrochloride (EDC), N-
Hydroxysuccinimide (NHS), and ethanolamine 
(EA), Phosphoric acid (PPA) and PBS buffer, 
were all purchased and used for the sensor surface 
fabrication. The surface functionalization 
procedures are shown in Fig 13. The AAO thin 
film would be bonded to the PDMS layer on the 
glass substrate as the first step. Then, the device 
would be immersed in 𝐻𝑆𝐶01𝐶𝑂𝑂𝐻/𝐻𝑆𝐶3𝑂𝐻 
for overnight and washed with ethanol and DI 
water. The device would be immersed in 
NHS/EDC for 2 hours after the surface is dried. 
Then, the surface would be immersed with 10 μM 
antibody solution overnight. The last step is 
loading ethanolamine (EA), which is able to 
block the non-occupied EDC/NHS activated 𝐻𝑆𝐶01𝐶𝑂𝑂𝐻/𝐻𝑆𝐶3𝑂𝐻  sites, followed by 
rinsing with the PBS buffer. The sensor is ready 
to take measurement as shown in Fig 13 (E). 
 As shown in Fig 12, there’s a main input0 
at the center of the device, which is connected to 
all 4 sensors. Each sensor has its own sub-inlet 
and sub-outlet, which is connected to the specific 
sensor. The width of the microfluidic network 
channels was designed for one-way flow, which 
means the chemicals can flow into all four 
Fig 12. (A-C) Photo of the device with four sensors, there’s one 
main inlet input0 and sub-inlet and sub-outlet for each sensors. (D) 
Schematic of the device and the operational principle. 
Fig 13. (A-E) Surface functionalization steps for the sensor. (F) 
Biomarker is applied to the sensor 
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sensors from the main inlet input0 but cannot 
flow back from the sensors. The chemicals in 
procedures shown in Fig 13 from (A) to (C) were 
all loaded from the main inlet input0 to all four 
sensors. The Aβ42 or T-tau antibody was flowed 
from the sub-inlet into each specific sensor. 
Different antibody flowed into each sensor allows 
multiplexed detection for different biomarkers on 
this single device.  
 The setup of the research is same as Fig 
3 (a), which used a white light source illuminated 
perpendicularly on the sensor surface, the 
spectrometer would collect the reflected optical 
signal and the shift of the optical interference 
fringes would be analysis corresponding to the 
concentration of both biomarkers. 
 
2.3.2. Results and Discussion 
 The concentrations of Aβ42 and T-tau 
buffers has been diluted. Aβ42 buffer 
concentrations were 3.9 pg/ml, 7.8 pg/ml, 15.6 
pg/ml, 31.2 pg/ml, 62.5 pg/ml, 125 pg/ml, 250 
pg/ml and 500 pg/ml. T-tau buffer concentrations 
were 15.6 pg/ml, 31.25 pg/ml, 62.5 pg/ml, 125 
pg/ml, 250 pg/ml, 500 pg/ml, 1000 pg/ml and 
2000 pg/ml. 
The detection performed on both 
biomarkers Aβ42 or T-tau in each buffer with 
Aβ42 and T-tau sensors and four plots had been 
created as shown in Fig 14. It indicated that the 
lowest concentration of Aβ42 that can be detected 
is 7.8 pg/ml and the shift of the peak reached 6.5 
nm when the concentration of Aβ42 increase to 
500 pg/ml as shown in Fig 14 (A). For the T-tau 
sensor, the lowest concentration of T-tau that can 
be detected is 15.6 pg/ml and the shift of the peak 
reached 3.76 nm when the concentration of T-tax 
increase to 2000 pg/ml as shown in Fig 14 (C). It 
has been proved that the concentration of these 
two biomarkers are both within the measuring 
range of the Aβ42 sensor and T-tau sensor.  
The plots in Fig (B) and (D) show the 
detection of the T-tau with the Aβ42 sensor and 
detection of the Aβ42 with the T-tau sensor. The 
results indicated that both Aβ42 sensor and T-tau 
sensor have a great specificity to measuring the 
corresponding biomarkers.  
Then, the detection of the biomarkers in 
CSF had been performed. CSF sample from 
Pooled Human Donors itself contains both Aβ42 
and T-tau and the concentrations were unknown. 
The Aβ42 samples with concentrations 500 
pg/ml, 250 pg/ml, 125 pg/ml and 62.5 pg/ml were 
prepared and spiked into same volume of CSF. 
Four Aβ42-CSF samples had been obtained with 
unknown concentrations. These four Aβ42-CSF 
samples had been used to measure the Aβ42 level 
with comparison from four Aβ42-buffer samples 
with known concentrations (500 pg/ml, 250 
pg/ml, 125 pg/ml and 62.5 pg/ml ). The results 
have been shown in Fig 15 (A) and the shift of the 
reflected signal is larger from the Aβ42-CSF 
sample when the Aβ42 concentration is below 
500 pg/ml. The shift from the Aβ42 buffer 
became larger when the concentration reached 
500 pg/ml. The intersection point between two 
plots is at 400 pg/ml, which is the original 
concentration in CSF sample. 
Then, the four Aβ42-CSF samples are 
spiked to the T-tau samples with same 
concentrations of 1000 pg/ml. The ratio of the 
volumes of Aβ42, T-tau and CSF are 1:1:1 and 
the concentrations of both biomarkers were 
Fig 14. (A) Measured reflected signal of Aβ42 sensor detecting Aβ42. 
(B) Measured reflected signal of Aβ42 sensor detecting T-tau. 
(C) Measured reflected signal of T-tau sensor detecting T-tau. 
(D) Measured reflected signal of T-tau sensor detecting Aβ42. 
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unknown. The detection of both Aβ42 and T-tau 
on these four samples were performed by the 
Aβ42 sensor and the results were plotted in Fig 
15 (B), which indicated a great specificity of the 
Aβ42 sensor because the T-tau biomarker only 
had a very small optical signal change. 
To be used as a multiplexed detection 
sensor, multiple Aβ42-T-tau-CSF mixture 
samples had been prepared and measured with 
both Aβ42 and T-tau sensors. The results have 
been shown in Fig 16. Fig 16 (A) indicates the 
measured optical reflected signal changes 
performed by the Aβ42 sensor and the 3-D plots 
shown the specificity of the sensor on measuring 
Aβ42 within the sample. Fig 16 (B) shows the 
measurement performed by the T-tau sensor and 
the plots indicated the specificity on the T-tau. 
The results of the research demonstrate 
that the device is able to detect Aβ42 and T-tau 
within the CSF sample successfully. The typical 
detection time is within 20 minutes, which is 
more time-efficient and less challenge than the 
neuroimaging methods. This device is a great 
diagnosis tools for point-of-care (POC) with high 
sensitivity and specificity [5]. 
 
2.4. High-resolution, flexible, and transparent 
nanopore thin film sensor [11] 
2.4.1. Introduction and Methods 
 To improve the flexibility and optical 
resolution of the anodic aluminum oxide (AAO) 
nanopore thin film significantly, the pTF-
nanopore sensor was introduced in this research 
by bonding a layer of transparent AAO thin film 
to a transparent polymer thin film (pTF), which is 
made with polydimethylsiloxane (PDMS). By 
bonding two Fabry-Perot cavities as cascaded, 
which are the AAO thin film and pTF layer, the 
limit of detection (LOD) of biochemical can be 
improved. To evaluate the resolution of the 
nanopore sensors, the quality (Q) factor will be 
used to determine, which is given by 𝑄 = 𝜆/ᇫ𝜆, 
where λ is the peak wavelength of the 
Fig 15. (A) Measured signal of Aβ42 from Aβ42 buffer 
and Aβ42-CSF sample. (B) Measured signal of Aβ42 
and T-tau from Aβ42-T-tau mixture with Aβ42-sensor. 
Fig 16. (A) Measured signals from both biomarkers 
with Aβ42 sensor. (B) Measured signals from both 
biomarkers with T-tau sensor. 
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interference fringes andᇫ𝜆 is the full width at 
half-maximum (FWHM) of it. Larger the Q factor 
is, better the optical resolution would be. 
 To fabricate the pTF-nanopore-sensor, a 
thin layer of PDMS would be coated onto the 
surface of the AAO nanopore thin film and the 
pTF with the AAO thin film will be peeled off 
form the glass substrate after being baked at 70℃ 
for 2 hours. The procedures are shown in the Fig 
17 (a) and the photos of the device are shown in 
Fig 17 (a-d), where the size of the nanopore is 30 
nm.  
 The setup of the experiment is similar 
with previous researches as shown in Fig 18. The 
thickness of the pTF layer is 50 μm, the thickness 
of the AAO layer is 2 μm and the resolution of 
the spectrometer is 0.22 nm.  
 
2.4.2. Results and Discussion 
 As shown in Fig 18 (d), the Q factor of 
the pTF-nanopore-sensor had been improved 
over 20 times than the AAO thin film from 20.5 
to 439.8 at 618 nm. However, when the thickness 
of the pTF layer become much larger, the 
transducing signal was unable to be resolved 
because the interference patterns of such device 
is much smaller than the spectrometer resolution. 
To prove this assumption, the pTF with 3000 μm 
thickness had been fabricated and the lower 
resolution spectrometer had been used, which are 
0.01, 0.04, and 0.2 nm. The spectral range of the 
measurement were shown from 590 to 594 nm for 
clarity in Fig 19 (a-d). When the spectrometer 
resolution is 0.22 nm and 0.2 nm, the sub-
interference fringes became very sparse and 
almost impossible to inspect as shown in Fig 19 
(a) and (d). In Fig 19 (b) and (c), the interference 
fringes shown clearly with the spectrometer with 
resolution 0.01 and 0.04 nm and provided much 
higher Q factor. This indicated that the resolution 
of the spectrometer is also an important factor 
needed to be considered during the designing 
processes. 
 The pTF layer with the thickness from 0 
μm to 80 μm with the 0.22 nm resolution 
spectrometer. The Fig 20 shown the calculated 
and the measured optical reflected signal and the 
results prove that when the thickness of the pTF 
Fig 17. (a) Fabrication procedures of pTF-nanopore 
sensor. (b-c) photos of the device. (d) SEM image of the 
nanopore thin film surface. 
Fig 18. (a-c) Experiment setup and the close look at the 
measuring. (d) The reflected interference fringes from the 
AAO, pTF, and the pTF-nanopore sensor with their Q factor 
Fig 19. (a-d) Measured optical signal for pTF-nanopore 
sensor with a thickness of the pTF of 3000μm with 
spectrometer with resolution 0.01, 0.04, 0.2 and 0.22 nm. 
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layer increase, the Q factor of the device would 
also increase. At the wavelength 618 nm, the 
FWHM of a pTF-nanopore-sensor with 80 μm 
pTF can be as low as 0.4 nm and the Q factor 
would reach 1544 in this case.  
 
 
 The pTF-nanopore-sensor is also can 
detect the angle change by monitoring the optical 
transducing signal. The results are shown in Fig 
21. AAO-nanopore-sensor and pTF-nanopore-
sensor were both tested during the research. 
AAO-nanopore-sensor didn’t detect any peak 
shift when the angle changes from 5° to 7° as 
shown in Fig 21 (a-c). The peak shift was clearly 
observed with the pTF-nanopore-sensor as shown 
in Fig 21 (d-f), which provide the angle 
sensitivity at 0.4 nm/deg. 
 Additionally, this device was 
temperature sensing, and in order to test this 
property, two pTF-nanopore-sensors were 
fabricated. The first one had 2 μm AAO thickness 
and 1.4 mm pTF layer thickness. The second 
device had 2 μm AAO thickness and 80 μm pTF 
layer. The Fig 22 shows the results of measuring 
the temperature from both devices. The Fig 22 (a-
c) show the results from the first device and 
there’s no peak shift observed when the 
temperature was changed from 25℃ to 30℃. 
With the 80 μm pTF-nanopore-sensor device, 
sub-interference fringes were clearly observed as 
shown in Fig 22 (d-f) and the temperature 
sensitivity of this device is 0.2 nm/℃. 
 Based on the research results, the typical 
thickness of the pTF layer of the device would be 
80 μm and the thickness of the AAO layer is 2 
μm. The pTF-nanopore-sensor not only increased 
the optical resolution significantly compared with 
AAO nanopore sensor that used in previous 
Fig 20. (a) Calculated spectrum for the device.  (b) 
Measured spectrum for the device 
Fig 21. (a-c) Calculated and measured results of AAO nanopore 
sensor for the angle change (d-f) Calculated and measured 
results of pTF nanopore sensor for the angle change 
Fig 22. (a-c) Calculated and measured results of pTF-nanopore 
sensor with 14 mm pTF for the temperature change. (d-f) 
Calculated and measured results of pTF-nanopore sensor with 
80 μm pTF for the temperature change. 
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research, it also can be used for angle 
measurement and temperature sensing. Also, 
great transparency and high flexibility provided 
this device with a potential to be used as wearable 
sensor to monitor disease biomarkers [11]. 
 
3. Conclusion 
The usage of AAO materials within 
biomedical industry has been increased in last 
few decades, how to improve the flexibility and 
the transducing signal resolution are still a 
challenge for people. The devices that were 
developed and performed research on are all 
based on the Anodic Aluminum Oxide, which has 
a honeycomb shape nanopore, which is able to 
store and release the drugs. Since the thickness of 
the drug layers is changing with drug loading or 
releasing process, the refractive index is also 
changed. By observing the reflected interference 
fringes as transducing signal with certain 
resolution spectrometer, the shifts of the 
wavelength peak can be related with number of 
layers on the surface so that the processes of drug 
loading and releasing can be monitored. After 
modifying the AAO sensors, this nanopore 
optical sensor is able to measure the 
concentration of a certain biomarkers in buffer 
with high specificity. The flexibility and accuracy 
are also improved significantly by bonding the 
AAO nanopore thin film to a polymer thin film 
(pTF), which make the wearable biomarker 
detectors possible. With these technologies, 
there’s other applications and researches 
performed in our lab, such as AAO nanopore thin 
film based optofluidic chip used to measure the 
serum prostate cancer biomarker developed in 
2015 [20] and AAO-nanopore based sensor used 
for theophylline detection [21]. More 
applications based on the pTF-nanopore optical 
sensors would be developed and the properties of 
the device would keep being improved in our lab 
in the future. 
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